Journal
CARDIOVASCULAR PATHOLOGY
Volume 22, Issue 2, Pages 126-132Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.carpath.2012.07.005
Keywords
Abdominal aortic aneurysm; Extracellular matrix; Matrix metalloproteinase; Transforming growth factor-beta
Categories
Funding
- National Health and Medical Research Council [540404, 1021416]
- BUPA Foundation
- National Health and Medical Research Council, Australia [1019921]
- Queensland Government
Ask authors/readers for more resources
Abdominal aortic aneurysms (AAAs) are common problems in aged people which can be associated with severe complications including aortic rupture and death. Transforming growth factor-beta (TGF beta) has been implicated as causative in the development of thoracic aortic aneurysms (TAAs). In contrast, current evidence suggests TGF beta inhibits AAA development. Polymorphisms in the TGF beta signaling components are associated with AAA in some human population studies. In experimental animals TGF beta protects against AAA formation, progression and rupture. In animal models of AAA TGF beta decreases aortic inflammatory cell infiltration, extracellular matrix degradation, and vascular smooth muscle cell apoptosis, all factors implicated in AAA pathogenesis. The TGF beta signaling pathway may provide a therapeutic target for AAA although better clarity is needed regarding the distinct roles of TGF beta in TAA and AAA. (C) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available